Cabaletta Bio (CABA) EBIT (QoQ) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Cabaletta Bio | 194.84 Mn | 61.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 8.54% |
| Sep 30, 2025 | -1.49% |
| Jun 30, 2025 | -23.62% |
| Mar 31, 2025 | -9.92% |
| Dec 31, 2024 | -2.24% |
| Sep 30, 2024 | -9.14% |
| Jun 30, 2024 | -8.02% |
| Mar 31, 2024 | -21.11% |
| Dec 31, 2023 | -23.99% |
| Sep 30, 2023 | -17.48% |
| Jun 30, 2023 | 6.29% |
| Mar 31, 2023 | -4.01% |
| Dec 31, 2022 | -38.41% |
| Sep 30, 2022 | 9.82% |
| Jun 30, 2022 | -0.47% |
| Mar 31, 2022 | 6.43% |
| Dec 31, 2021 | -20.15% |
| Sep 30, 2021 | -3.75% |
| Jun 30, 2021 | -14.75% |
| Mar 31, 2021 | -4.09% |
| Dec 31, 2020 | -10.86% |
| Sep 30, 2020 | -2.73% |
| Jun 30, 2020 | -3.76% |
| Mar 31, 2020 | -34.73% |
| Dec 31, 2019 | -16.48% |
| Sep 30, 2019 | -32.33% |
| Jun 30, 2019 | 4.71% |
| Mar 31, 2019 | -93.22% |
| Dec 31, 2018 | 32.95% |